Page last updated: 2024-08-21

cytidine diphosphate choline and Cranial Nerve II Injuries

cytidine diphosphate choline has been researched along with Cranial Nerve II Injuries in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, T; Bikbova, G; Kitamura, Y; Oshitari, T; Yamamoto, S1
Huang, J; Huang, Y; Jiang, J; Wang, W; Zhang, J1
Bolz, S; Grieb, P; Junemann, A; Lehaci, C; Mankowska, A; Rejdak, R; Schuettauf, F; Thaler, S; Zagorski, Z; Zarnowski, T; Zrenner, E1

Other Studies

3 other study(ies) available for cytidine diphosphate choline and Cranial Nerve II Injuries

ArticleYear
In vivo effects of single or combined topical neuroprotective and regenerative agents on degeneration of retinal ganglion cells in rat optic nerve crush model.
    Scientific reports, 2019, 01-14, Volume: 9, Issue:1

    Topics: Administration, Topical; Animals; Cell Count; Cytidine Diphosphate Choline; Disease Models, Animal; Drug Therapy, Combination; Histocytochemistry; Immunohistochemistry; Nerve Growth Factors; Neuroprotective Agents; Optic Nerve Injuries; Rats, Sprague-Dawley; Retinal Ganglion Cells; Taurochenodeoxycholic Acid; Treatment Outcome

2019
Efficacy of cytidine-5'-diphosp-bocholine combined with compound anisodine in the treatment of early optic nerve contusion.
    Eye science, 2012, Volume: 27, Issue:1

    Topics: Contusions; Cytidine Diphosphate Choline; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Male; Mannitol; Middle Aged; Optic Nerve Injuries; Scopolamine Derivatives; Treatment Outcome; Visual Acuity

2012
Citicoline and lithium rescue retinal ganglion cells following partial optic nerve crush in the rat.
    Experimental eye research, 2006, Volume: 83, Issue:5

    Topics: Animals; Apoptosis; Cell Count; Cytidine Diphosphate Choline; Disease Models, Animal; Female; Immunohistochemistry; Lithium; Microscopy, Fluorescence; Neuroprotective Agents; Optic Nerve Injuries; Pharmaceutical Vehicles; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Inbred BN; Retinal Ganglion Cells

2006